Disc’s once-spurned rare disease drug to get a second chance at approval
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
Meet Sasha Bogosian, the 18-year-old Los Angeles student who started painting jeans while recovering from leg surgery at 8; a decade later, her nonprofit has raised nearly $100,000 for children’s hospital art therapy
An 18-year-old student from Los Angeles who began painting denim while recovering from major bone surgery at the…
Avoid chicken fed salmon by eating Irish salmon – food expert
The best way to avoid eating chicken fed salmon is to buy Irish salmon, a food expert has…
How to start strength training in midlife – a trainer’s simple 3-move approach
As you get older, you may notice you have more pesky aches and pains in your joints, find…
Increased risk-taking behavior precedes higher alcohol consumption, study finds
A novel study has found that increases in risk-taking behavior in people with mild to moderate alcohol use…
Is Praxis Precision Medicines (PRAX) Priced Too Highly On Book Value?
Praxis Precision Medicines has delivered a very large 3 year share price gain, yet recent pullbacks and a…
Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress
First Phase 1 data for sofetabart mipitecan, Lilly’s investigational FRα-targeting ADC, in platinum-sensitive ovarian cancer to be featured…
The rise of peptides: How the wellness craze is outpacing the science – WHYY
The rise of peptides: How the wellness craze is outpacing the science WHYYSpike in Australian ED admissions due to…
Jade Cargill Says Looking Good Naked Is a Bonus of Her Intense Workout Routine
Jade Cargill spends plenty of time in the gym maintaining one of the most recognizable physiques in WWE,…
Podcast: Thyroid Pitfalls in Psychiatric Practice, From Lab Interpretation to Wellness Supplements
Wellness Trends Patients increasingly arrive taking thyroid-related supplements. Low-dose T3, around 5 mcg, is unlikely to cause harm…
MHRA authorises plozasiran (Redemplo) for adults with familial chylomicronaemia syndrome
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 October 2026, authorised plozasiran (Redemplo) to reduce…
ADHD Drugs May Reduce The Risk of Early Death, Major Study Finds : ScienceAlert
People with ADHD face more than issues with attention, focus, and impulses: It’s a serious condition that may…